Skip to main content

Table 2 Factors associated with mortality in patients with E. coli or Klebsiella spp. bacteremia

From: Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study

 

Death

Survival

p

RR (95 % CI)

 

(n = 81)

(n = 306)

  

Demographics

 Men

57 (70.4)

207 (61.8)

0.1

1.36 (0.89-2.09)

 Age > 65 y

61 (75.3)

219 (71.6)

0.3

1.17 (0.74-1.83)

Place of acquisition

 Community acquired

13 (16)

97 (31.7)

0.003

0.41 (0.22-0.78)

 Health care associated

25 (30.9)

112 (36.6)

0.2

0.82 (0.53-1.24)

 Nosocomial

43 (53.1)

97 (31.7)

<0.001

2 (1.36-2.93)

Origin of infection

 Urinary

38 (46.9)

177 (57.8)

0.05

0.71 (0.48-1.04)

 Biliary

8 (9.9)

41 (13.4)

0.26

0.76 (0.39-1.47)

 Unknown

9 (11.1)

28 (9.2)

0.36

1.18 (0.64-2.16)

 Intra-abdominal

11 (13.6)

23 (7.5)

0.07

1.63 (0.96-2.77)

 Pneumonia

8 (9.9)

20 (6.5)

0.21

1.41 (0.75-2.61)

 Catheter

3 (3.7)

13 (4.2)

0.56

0.89 (0.32-2.52)

Comorbidity

 Diabetes

21 (25.9)

91 (29.7)

0.3

0.86 (0.55-1.34)

 Ictus

15 (18.5)

55 (18)

0.51

1.03 (0.63-1.69)

 Dementia

16 (19.8)

50 (16.3)

0.28

1.2 (0.74-1.93)

 COPD

15 (18.5)

50 (16.3)

0.38

1.12 (0.69-1.84)

 Chronic renal failure

20 (24.7)

48 (15.7)

0.05

1.54 (1-2.37)

 Cardiac failure

15 (18.5)

41 (13.4)

0.16

1.34 (0.83-2.18)

 Liver cirrhosis

16 (19.8)

28 (9.2)

0.009

1.92 (1.23-3)

 Cancer

33 (40.7)

78 (25.5)

0.006

1.71 (1.17-2.51)

 Metastatic tumor

13 (16)

20 (6.5)

0.009

2.05 (1.28-3.3)

 Immunosuppression

16 (19.8)

49 (16)

0.25

1.22 (0.76-1.97)

 Charlson ≥3

60 (74.1)

149 (48.7)

<0.001

2.43 (1.54-3.84)

Microbiology

E. coli

65 (80.2)

278 (90.8)

0.009

0.52 (0.33-0.82)

 Multidrug resistant

45 (55.6)

132 (43.1)

0.03

1.48 (1-2.19)

Presentation

 Sepsis severe or shock

57 (70.4)

68 (22.5)

<0.001

4.9 (3.2-7.51)

 Adequate empirical therapy

34 (42)

164 (53.6)

0.04

0.69 (0.47-1.02)

 Adequate change for definitive therapy

29 (32.1)

109 (35.6)

0.33

0.88 (0.58-1.34)

  1. Date are no. (%) of patients.